Bruker Corporation BRKR recently announced a new technology, EpicIF (Enhanced photobleaching in cyclic immunofluorescence), to further enhance the CellScape Precise Spatial Proteomics platform for ...

With this new technology, Bruker has further advanced the CellScape chemistry with EpicIF (Enhanced photobleaching in cyclic ...

This research provides a quantitative analysis of the fibroblast-to-myofibroblast transition (FMT), a critical process in ...

Western blot (or indirect immunofluorescence assay): Like the screening tests, this checks to see if your body has made antibodies to fight the virus. Don't let worry over an HIV test stop you ...

RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY CONFERENCEParsortix-based HER2 kit being developed to provide an optimised, easily implemented, ...

Bruker on Tuesday rolled out new technology for its CellScape™ Precise Spatial Proteomics platform for highly multiplexed immunofluorescence ... as well as simplify assay development, and ...

CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may help to advance personalised treatment GUILDFORD, UNITED KINGDOM / ACCESSWIRE / November 15, 2024 / ...

POLK expression in neurons and report an important observation that POLK exhibits an age-dependent change in subcellular localization, from the nucleus in young tissue to the cytoplasm in old tissue.

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.